Mindray Patient Monitoring 迈瑞医疗
China · Shenzhen
alternative to Philips / GE HealthCare / Dräger
BeneVision and ePM patient monitors with central monitoring, A-series anaesthesia machines, SV-series ICU ventilators and BeneHeart defibrillators for hospital wards, ICUs and operating rooms. International business made up 53% of Mindray's revenue in H1 2026.
Why it fits
- Patient Monitoring
- Global-ready
Regional alternatives
Product facts
- Segment
- Patient Monitoring
- Role
- Manufacturer
H1 2026 interim results (Aug 2026): international business CNY 9.47B, 53% of revenue. Mindray says most of its patient-monitoring and life-support product lines ranked #1 in China by 2025 revenue.
Market authorizations
United States
European Union
- CE marked (MDR): A-series anaesthesia systems (A8/A9 and A4–A70 families)CN24/00005514 · SGS Belgium NV (1639) · decided 2024-09-30 · valid through 2029-08-29 Source (checked 2026-10)
Verified records only; absence here does not mean a product is unauthorized.
Regulatory & supply-chain notes
EU · procurement ban
Tenders from Chinese suppliers are excluded from EU public procurement of medical devices (CPV 331) worth €5 million or more, until 30 June 2030; winning bidders may source at most 50% of the contract value from China. An EU-based subsidiary with real business in the EU may bid, but its China-made devices count toward that 50%. Smaller tenders and private buyers are not affected.
International Procurement Instrument · Medical devices from China in EU public tenders of €5 million or more · effective 2025-06-30 · source ↗
Company & market
- Parent company
- Shenzhen Mindray Bio-Medical Electronics
- Registered
- Shenzhen
- Listing
- A-share
- Ticker
- 300760.SZ
- Market cap / val. (USD)
- ~$30 B
- Foreign-investable
- No